Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery
Authors
Keywords
Alzheimers disease, Cognitive impairment, Dementia, Drug discovery, Positron emission tomography, Cerebrospinal fluid, Clinical trials, Clinical pathology
Journal
PLOS MEDICINE
Volume 14, Issue 3, Pages e1002256
Publisher
Public Library of Science (PLoS)
Online
2017-03-15
DOI
10.1371/journal.pmed.1002256
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of interventions to reduce Alzheimer's disease pathology on the prevalence of dementia in the oldest-old
- (2016) Ron Brookmeyer et al. Alzheimers & Dementia
- TDP-43 stage, mixed pathologies, and clinical Alzheimer’s-type dementia
- (2016) Bryan D. James et al. BRAIN
- Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study
- (2016) Zoe Arvanitakis et al. LANCET NEUROLOGY
- Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies
- (2016) Lon R. White et al. NEUROLOGY
- Higher brainBDNFgene expression is associated with slower cognitive decline in older adults
- (2016) Aron S. Buchman et al. NEUROLOGY
- Trends in autopsy-verified dementia prevalence over 29 years of the Hisayama study
- (2016) Hiroyuki Honda et al. NEUROPATHOLOGY
- Residual decline in cognition after adjustment for common neuropathologic conditions.
- (2015) Lei Yu et al. NEUROPSYCHOLOGY
- Age, Sex, andAPOEε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span
- (2015) Clifford R. Jack et al. JAMA Neurology
- Potential for primary prevention of Alzheimer's disease: an analysis of population-based data
- (2014) Sam Norton et al. LANCET NEUROLOGY
- Alzheimer’s disease drug-development pipeline: few candidates, frequent failures
- (2014) Jeffrey L Cummings et al. Alzheimers Research & Therapy
- Much of late life cognitive decline is not due to common neurodegenerative pathologies
- (2013) Patricia A. Boyle et al. ANNALS OF NEUROLOGY
- Prevalence of dementia subtypes in a developing country: a clinicopathological study
- (2013) LT Grinberg et al. Clinics
- Adult Changes in Thought Study: Dementia is an Individually Varying Convergent Syndrome with Prevalent Clinically Silent Diseases that may be Modified by Some Commonly Used Therapeutics
- (2013) Thomas J. Montine et al. Current Alzheimer Research
- Neural reserve, neuronal density in the locus ceruleus, and cognitive decline
- (2013) R. S. Wilson et al. NEUROLOGY
- Very low levels of education and cognitive reserve: A clinicopathologic study
- (2013) J. M. Farfel et al. NEUROLOGY
- Ecology of the Aging Human Brain
- (2011) Joshua A. Sonnen ARCHIVES OF NEUROLOGY
- Multiple Biological Pathways Link Cognitive Lifestyle to Protection from Dementia
- (2011) Michael J. Valenzuela et al. BIOLOGICAL PSYCHIATRY
- Education, the brain and dementia: neuroprotection or compensation?
- (2011) Carol Brayne et al. BRAIN
- The neuropathology of probable Alzheimer disease and mild cognitive impairment
- (2009) Julie A. Schneider et al. ANNALS OF NEUROLOGY
- The Nun Study: Clinically silent AD, neuronal hypertrophy, and linguistic skills in early life
- (2009) D. Iacono et al. NEUROLOGY
- Age, Neuropathology, and Dementia
- (2009) George M. Savva et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiological Pathology of Dementia: Attributable-Risks at Death in the Medical Research Council Cognitive Function and Ageing Study
- (2009) Fiona E. Matthews et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More